This prospective study aimed to evaluate the diagnostic utilities of neutrophil CD64 expression for the identification of early-onset clinical infection and pneumonia in term infants and to define the optimal cutoff value so that it may act as a reference with which future studies can be compared. Term newborns in whom infection was suspected when they were Ͻ72 h of age were recruited into the study. C-reactive protein (CRP) and expression of CD64 on neutrophils were measured at 0 h (at the time of sepsis evaluation) and 24 h. The sensitivity, specificity, positive predictive value, and negative predictive value (NPV) of CRP, CD64, and the combination of these two markers for predicting neonatal sepsis were determined. A total of 338 infants with suspected clinical sepsis were investigated, 115 of whom were found to be clinically infected. CRP and CD64 in infected infants were both significantly elevated at 0 and 24 h compared with noninfected infants (p Ͻ 0.001). The calculated optimal cutoff value for CD64 was 6136 antibody-phycoerythrin molecules bound/cell. CD64 has a very high sensitivity (96%) and NPV (97%) at 24 h. The addition of CRP only marginally enhanced the sensitivity and NPV (97 and 98%, respectively). In conclusion, neutrophil CD64 is a very sensitive diagnostic marker for the identification of early-onset clinical infection and pneumonia in term newborns. The results strongly suggest that measurement of neutrophil CD64 may allow neonatal clinicians to discontinue antibiotic treatment at 24 h in infants who are clinically stable and whose CD64 expressions are below the optimal cutoff level. Early-onset (Ͻ72 h of age) neonatal infection is associated with a high morbidity and mortality (1). Immature immunologic defenses in newborn infants, including low circulating levels of immunoglobulins, decrease in absolute number of T lymphocytes and neutrophils, and functionally impaired cytotoxic activity in leukocytes (2-4), are important risk factors that predispose these infants to life-threatening sepsis. Early clinical signs and symptoms of neonatal infection and pneumonia are often inconspicuous and can easily be confused with other noninfective causes, such as transient tachypnea of the newborns, meconium aspiration syndrome, congenital heart diseases, and hypoxic-ischemic encephalopathy (5). Thus, there is always a possibility that the attending neonatologists may overlook or miss subtle cases of early infection. In view of the potentially serious outcome associated with delayed treatment and the difficulty in distinguishing infected from noninfected cases, it has become common practice to prescribe broad-spectrum antibiotics for suspected infection that presents with nonspecific clinical features and maternal risk factors (5-7). Furthermore, as negative microbiologic culture results do not always suggest the absence of bacterial sepsis, continuation of antimicrobial therapy for presumptive infection frequently leads to unnecessary and prolonged treatment and increases in duration of hospitalizatio...